Propionic Acid

Propionic Acid

SCHEMBL4157930

CCC(=O)O.O=c1[nH]c2ccc(S(=O)(=O)Cc3ccccn3)cc2c2cc[nH]c12

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
RXFP1 Q9HBX9 1/20 0.38
BRAF P15056 6/20 0.37
PARG Q86W56 1/20 0.36
ALDH1A1 P00352 3/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
HPGD P15428 2/20 0.34
MEN1 O00255 1/20 0.34
USP2 O75604 1/20 0.34
HSP90AA1 P07900 1/20 0.34
HSP90AB1 P08238 1/20 0.34
YWHAG P61981 1/20 0.34
KMT2A Q03164 1/20 0.34
PARP1 P09874 2/20 0.34
KDM4E B2RXH2 1/20 0.33
GABRA1 P14867 1/20 0.33
GABRB2 P47870 1/20 0.33
PTPN11 Q06124 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propionic Acid SCHEMBL4162521 0.86 FEN1 (0.44) RXFP1BRAFALDH1A1MEN1KMT2A
Propionic Acid SCHEMBL4171787 0.84 BRAF (0.38) RXFP1BRAFKDM4E
Propionic Acid SCHEMBL4153947 0.82 MET (0.45) RXFP1ALDH1A1PARP1KDM4EPTPN11
Propionic Acid SCHEMBL4155193 0.80 RXFP1 (0.41) RXFP1BRAFALDH1A1HPGDMEN1
Propionic Acid SCHEMBL4166927 0.79 RXFP1 (0.47) RXFP1ALDH1A1HPGDMEN1USP2
Propionic Acid SCHEMBL4162918 0.79 BRAF (0.46) RXFP1BRAFKDM4E
SCHEMBL3249036 0.79 TET2 (0.36) BRAFPARGALDH1A1NPC1RAB9A
Propionic Acid SCHEMBL4163285 0.78 PKM (0.54) BRAFPARP1
SCHEMBL4157925 0.78 PNP (0.37) BRAFPARGALDH1A1NPC1RAB9A
Propionic Acid SCHEMBL4162945 0.77 KDM4E (0.47) RXFP1ALDH1A1HPGDMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8426437-B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors PIERRE FABRE MEDICAMENT (FR) 2013-04-23 US claimed
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US claimed
US-8426437-B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors PIERRE FABRE MEDICAMENT (FR) 2013-04-23 US disclosed
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors MAP3K1, MAP3K2, MAP3K7 RXFP1 3999/4885BRAF 38/4885PARG 3507/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.